AstraZeneca PLC provided earnings guidance for the fiscal year 2022. The company expects total revenue to increase by a high teens percentage and Core EPS is expected to increase by a mid-to-high twenties percentage.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,364 GBX | +2.22% | +0.96% | +16.64% |
07:40pm | US Equity Indexes Little Changed as Fed Officials Pepper Views on Policy Path, Investors Brace for Nvdia's Earnings | MT |
07:09pm | US Equity Indexes Slightly Higher in Midday Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.64% | 238B | |
+37.89% | 705B | |
+32.82% | 583B | |
-3.68% | 364B | |
+19.79% | 332B | |
+5.00% | 291B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.81% | 169B | |
-1.02% | 162B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca PLC Provides Earnings Guidance for the Fiscal Year 2022